BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28218005)

  • 1. Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.
    Wahidiyat PA; Liauw F; Sekarsari D; Putriasih SA; Berdoukas V; Pennell DJ
    Hematology; 2017 Sep; 22(8):501-507. PubMed ID: 28218005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Iron Overload Between Age Groups Using Magnetic Resonance Imaging and Its Correlation with Iron Profile in Transfusion-dependent Thalassemia.
    Wahidiyat PA; Iskandar SD; Sekarsari D
    Acta Med Indones; 2018 Jul; 50(3):230-236. PubMed ID: 30333273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Tissue Elastography With Magnetic Resonance Imaging T2* and Serum Ferritin Quantification in Detecting Liver Iron Overload in Patients With Thalassemia Major.
    Pipaliya N; Solanke D; Parikh P; Ingle M; Sharma R; Sharma S; Sawant P
    Clin Gastroenterol Hepatol; 2017 Feb; 15(2):292-298.e1. PubMed ID: 27650324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uses and limitations of serum ferritin, magnetic resonance imaging T2 and T2* in the diagnosis of iron overload and in the ferrikinetics of normalization of the iron stores in thalassemia using the International Committee on Chelation deferiprone/deferoxamine combination protocol.
    Kolnagou A; Yazman D; Economides C; Eracleous E; Kontoghiorghes GJ
    Hemoglobin; 2009; 33(5):312-22. PubMed ID: 19814677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
    Chaosuwannakit N; Makarawate P; Wanitpongpun C
    Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
    [No Abstract]   [Full Text] [Related]  

  • 6. Assessing cardiac and liver iron overload in chronically transfused patients with sickle cell disease.
    Badawy SM; Liem RI; Rigsby CK; Labotka RJ; DeFreitas RA; Thompson AA
    Br J Haematol; 2016 Nov; 175(4):705-713. PubMed ID: 27507431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver iron and serum ferritin levels are misleading for estimating cardiac, pancreatic, splenic and total body iron load in thalassemia patients: factors influencing the heterogenic distribution of excess storage iron in organs as identified by MRI T2*.
    Kolnagou A; Natsiopoulos K; Kleanthous M; Ioannou A; Kontoghiorghes GJ
    Toxicol Mech Methods; 2013 Jan; 23(1):48-56. PubMed ID: 22943064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of magnetic resonance imaging T2* tests in detecting heart and liver iron overload in patients with β-thalassemia major].
    Wu X; Jing Y; Pei F; Chen J; Feng X; He Y; Zhang Y; Li C
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):249-52. PubMed ID: 23443782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of HFE Gene Mutations With Serum Ferritin Level and Heart and Liver Iron Overload in Patients With Transfusion-dependent Beta-Thalassemia.
    Zekavat OR; Zareian Jahromi M; Haghpanah S; Kargar Jahromi Z; Cohan N
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e26-e28. PubMed ID: 32925401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of serum ferritin levels with hepatic MRI T2 and liver iron concentration in nontransfusion beta-thalassemia intermediate patients: A contemporary issue.
    Karimi M; Amirmoezi F; Haghpanah S; Ostad S; Lotfi M; Sefidbakht S; Rezaian S
    Pediatr Hematol Oncol; 2017 Aug; 34(5):292-297. PubMed ID: 29190176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrinopathies, metabolic disorders, and iron overload in major and intermedia thalassemia: serum ferritin as diagnostic and predictive marker associated with liver and cardiac T2* MRI assessment.
    Chirico V; Rigoli L; Lacquaniti A; Salpietro V; Piraino B; Amorini M; Salpietro C; Arrigo T
    Eur J Haematol; 2015 May; 94(5):404-12. PubMed ID: 25200112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac T2* MRI assessment in patients with thalassaemia major and its effect on the preference of chelation therapy.
    Akcay A; Salcioglu Z; Oztarhan K; Tugcu D; Aydogan G; Ayaz NA; Bornaun H; Sen HS; Akici F; Akdana B
    Int J Hematol; 2014 Jun; 99(6):706-13. PubMed ID: 24719246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlative study of iron accumulation in liver, myocardium, and pituitary assessed with MRI in young thalassemic patients.
    Christoforidis A; Haritandi A; Tsitouridis I; Tsatra I; Tsantali H; Karyda S; Dimitriadis AS; Athanassiou-Metaxa M
    J Pediatr Hematol Oncol; 2006 May; 28(5):311-5. PubMed ID: 16772883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between liver iron concentration determined by magnetic resonance imaging and serum ferritin in adolescents with thalassaemia disease.
    Chuansumrit A; Laothamathat J; Sirachainan N; Sungkarat W; Wongwerawattanakoon P; Kumkrua P
    Paediatr Int Child Health; 2016 Aug; 36(3):203-8. PubMed ID: 27595699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary iron excretion for evaluating iron chelation efficacy in children with thalassemia major.
    Wahidiyat PA; Wijaya E; Soedjatmiko S; Timan IS; Berdoukas V; Yosia M
    Blood Cells Mol Dis; 2019 Jul; 77():67-71. PubMed ID: 30978615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI for Quantification of Liver and Cardiac Iron in Thalassemia Major Patients: Pilot Study in Indian Population.
    Mandal S; Sodhi KS; Bansal D; Sinha A; Bhatia A; Trehan A; Khandelwal N
    Indian J Pediatr; 2017 Apr; 84(4):276-282. PubMed ID: 28233255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T2-star (T2*) magnetic resonance imaging for assessment of kidney iron overload in thalassemic patients.
    Hashemieh M; Azarkeivan A; Akhlaghpoor S; Shirkavand A; Sheibani K
    Arch Iran Med; 2012 Feb; 15(2):91-4. PubMed ID: 22292579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
    Voskaridou E; Douskou M; Terpos E; Papassotiriou I; Stamoulakatou A; Ourailidis A; Loutradi A; Loukopoulos D
    Br J Haematol; 2004 Sep; 126(5):736-42. PubMed ID: 15327528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and Risk Factors for Cardiac and Liver Iron Overload in Adults with Thalassemia in Malaysia.
    Ngim CF; Lee MY; Othman N; Lim SM; Ng CS; Ramadas A
    Hemoglobin; 2019 Mar; 43(2):95-100. PubMed ID: 31179787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.
    Karakas Z; Yilmaz Y; Bayramoglu Z; Karaman S; Aydogdu S; Karagenc AO; Tugcu D; Dursun M
    Radiol Med; 2018 Aug; 123(8):572-576. PubMed ID: 29663188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.